Heinrich Schlunken

Title: Heinrich Schlunken: Innovator in Medicinal Granulation

Introduction

Heinrich Schlunken is a notable inventor based in Linz, Austria. He has made significant contributions to the field of pharmaceutical granulation, holding a total of 2 patents. His work focuses on the development of binder-free granules for solid medicament forms, which are crucial in the pharmaceutical industry.

Latest Patents

Schlunken's latest patents include a process for the preparation of binder-free, tablettable granules. This innovative method involves using celiprolol hydrochloride with specific particle size distributions in a fluidized bed granulator. The process ensures the formation of free-flowing granules with optimal water content and particle size, which are then dried at controlled temperatures. Another significant patent is a method for simultaneously drying and granulating extract substances from deproteinized calves' blood. This method produces granules that are ready for compression and contain a high percentage of extract substances, ensuring stability and quality in solid medicament forms.

Career Highlights

Throughout his career, Schlunken has worked with reputable companies such as Hormon-Chemie München GmbH and Cl Pharma Aktiengesellschaft. His experience in these organizations has contributed to his expertise in pharmaceutical formulations and granulation techniques.

Collaborations

Heinrich Schlunken has collaborated with notable professionals in his field, including Otto Klug and Dietmar Siegel. These collaborations have further enhanced his innovative approaches to pharmaceutical development.

Conclusion

Heinrich Schlunken's contributions to the field of medicinal granulation demonstrate his commitment to advancing pharmaceutical technology. His patents reflect a deep understanding of the complexities involved in creating effective medicament forms.